商务合作
动脉网APP
可切换为仅中文
SILVER SPRING, Md.
马里兰州银泉市
,
,
March 18, 2025
2025年3月18日
/PRNewswire/ -- Today, under the leadership of U.S. Department of Health and Human Services Secretary
/PRNewswire/ -- 今天,在美国卫生与公众服务部部长的领导下
Robert F. Kennedy, Jr.
罗伯特·F·肯尼迪 Jr.
, the U.S. Food and Drug Administration is taking steps to enhance its efforts to ensure the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula supply.
美国食品和药物管理局正在采取措施,加强其确保国内婴儿配方奶粉供应持续质量、安全、营养充足性和弹性的努力。
'The FDA will use all resources and authorities at its disposal to make sure infant formula products are safe and wholesome for the families and children who rely on them,'
“FDA将利用其掌握的所有资源和权力,确保婴儿配方奶粉产品的安全和健康,以满足依赖这些产品的家庭和儿童的需求。”
said HHS Secretary Kennedy
卫生与公众服务部长肯尼迪说
. 'Helping each family and child get off to the right start from birth is critical to our pursuit to Make America Healthy Again.'
“帮助每个家庭和孩子从出生起就走上正确的起点,对我们实现‘让美国再次健康’的目标至关重要。”
The FDA is announcing a set of actions and initiatives focused on infant formula, such as beginning the nutrient review process and increasing testing for heavy metals and other contaminants. The agency is also encouraging companies to develop new infant formulas and clarify opportunities to help inform consumers about formula ingredients. These enhanced FDA commitments are focused on making sure a strong supply of the sole source of nutrition for formula-fed babies and children remains available for one of our nation's most vulnerable populations..
美国食品药品监督管理局(FDA)宣布了一系列针对婴儿配方奶粉的行动和举措,例如启动营养审查程序并加大对重金属及其他污染物的检测力度。该机构还鼓励企业开发新的婴儿配方奶粉,并明确机会以帮助消费者了解配方成分。这些加强的FDA承诺旨在确保为我国最脆弱群体之一——依赖配方奶粉喂养的婴儿和儿童——持续提供充足的唯一营养来源供应。
'The FDA is deeply committed to ensuring that moms and other caregivers of infants and young children and other individuals who rely on infant formula for their nutritional needs have confidence that these products are safe, consistently available, and contain the nutrients essential to promote health and wellbeing during critical stages of development and life,' .
“FDA深切致力于确保妈妈们和其他婴幼儿及依靠婴儿配方奶粉满足营养需求的其他人士有信心认为这些产品是安全的、始终有供应的,并含有在发育和生命关键阶段促进健康和福祉的基本营养素。”
said
说
Acting FDA Commissioner
代理FDA专员
Sara Brenner
萨拉·布伦纳
, M.D., M.P.H.
医学博士,公共卫生硕士
'Whether breastfed, bottle fed or both, the rising generation must be nourished in a way that promotes health and longevity over the course of their lives.'
“无论是母乳喂养、奶瓶喂养还是两者兼有,下一代必须以一种在其一生中促进健康和长寿的方式得到滋养。”
The FDA uses its authorities, both longstanding and newly granted, to uphold the safety, nutritional adequacy and resilience of infant formula and the infant formula supply. The FDA is:
美国食品药品监督管理局(FDA)利用其长期持有和新授予的权力,维护婴儿配方奶粉的安全性、营养充足性和弹性以及婴儿配方奶粉的供应。FDA正在:
Starting the nutrient review required by law by issuing a Request for Information in the coming months to start the first comprehensive update and review of infant formula nutrients by the FDA since 1998
将在未来几个月内发布信息请求,以启动自1998年以来FDA对婴儿配方奶粉营养成分的首次全面更新和审查,这是法律要求的营养审查的第一步。
Increasing testing for heavy metals and other contaminants in infant formula and other foods children consume
增加对婴儿配方奶粉和儿童食用的其他食品中的重金属和其他污染物的检测。
Extending the personal importation policy
延长个人进口政策
Encouraging companies to work with the FDA on any questions regarding increased transparency and clearer labeling
鼓励公司就提高透明度和更清晰标签的任何问题与FDA合作
Communicating regularly with consumers and industry stakeholders as significant developments occur to ensure transparency, including information regarding nutrients and health outcomes
在发生重大进展时,定期与消费者和行业利益相关者沟通,以确保透明度,包括有关营养素和健康结果的信息。
Collaborating with the National Institutes of Health and other scientific bodies to address priority scientific research gaps regarding short- and long-term health outcomes associated with formula feeding in infancy and childhood across the lifespan
与美国国立卫生研究院及其他科学机构合作,解决婴儿期和儿童期配方奶粉喂养对整个生命周期的短期和长期健康结果相关的重点科学研究空白。
The FDA remains committed to infant formula safety and nutritional quality and is taking all actions to ensure the U.S. infant formula supply ranks best in the world.
美国食品和药物管理局仍然致力于婴儿配方奶粉的安全和营养质量,并正在采取一切措施,确保美国的婴儿配方奶粉供应位居世界最佳之列。
Additional Resources:
额外资源:
FDA: Infant Formula
FDA:婴儿配方奶粉
Media Contact:
媒体联系人:
FDA Office of Media Affairs
FDA媒体事务办公室
, 301-796-4540
,301-796-4540
SOURCE U.S. Food and Drug Administration
来源:美国食品药品监督管理局
WANT YOUR COMPANY'S NEWS
想要贵公司的新闻吗?
FEATURED ON PRNEWSWIRE.COM?
刊登在PRNEWSWIRE.COM上?
440k+
44万+
Newsrooms &
新闻编辑室 &
Influencers
影响者
9k+
9k+
Digital Media
数字媒体
Outlets
插座
270k+
27万+
Journalists
记者
Opted In
已选择加入
GET STARTED
开始使用